 - Non-pregnant individuals ages 18 and older with a diagnosis of actively progressive skin lesions of clinically diagnosed vitiligo covering at 5 or great body surface area defined as development of new lesions or worsening of existing lesions within the past 6 months not receiving immune suppressive treatment. Both subjects who have received at least one therapy in the past and subjects currently receiving treatment at the time of screening will be eligible providing they undergo a wash out period prior to starting the study 2 weeks for topical agents and systemic agents with short half lives, 1 month for phototherapy 